PUF Ventures building 1 million sq. ft cannabis production facility in Australia
PUF Ventures, the Vancouver-based biomedical ACMPR applicant with a production facility in London, Ontario, has just announced a...
PUF ventures
PUF Signs Joint Venture Agreement with Canopy Growth Corporation
VANCOUVER, June 1, 2017 /CNW/ - PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Stage 5 Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, is very pleased to announce it has signed an exclusive joint venture agreement with Canopy Growth Corporation (TSX: WEED) (Canopy Growth) and joined CraftGrow, a collection of high quality cannabis grown by a select and diverse set of producers, made available through Tweedmainstreet.com.
PUF Ventures Grows Interest in Cannabis Grow
VANCOUVER, May 8, 2017 /CNW/ - PUF Ventures Inc. (the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF) announces that it has issued 500,003 common shares at a deemed price of $0.40 per share to the shareholders of AAA Heidelberg Inc. ("AAA") pursuant to the Share Exchange Agreement among the Company, AAA and the shareholders of AAA dated for reference January 26, 2015 (the "Agreement"). These shares are subject to a four month hold period. As result of this share issuance the number of issued and outstanding shares of the Company increased from 41,908,455 to 42,408,458.
PUF Ventures Added to Composite Index of Canadian Securities Exchange
PUF Ventures Inc. (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF) is very pleased to announce that it has been added...